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water bath at 120rpm. upernatants were pooled from the second to ifth digestions in a tube. Cells were re-suspended in alpha-modi ied agle s medium ( -, ibco, A) containing 10% ( / ) fetal bo ine serum (FB , ibco, A) with 1% penicillin/streptomycin solution (penicillin 100 /m , streptomycin 100 /m ) and then transferred in T-25 cm 2 culture las s. The las s were maintained in 5% CO2 incubator (Thermo cienti ic Forma eries Water-ac eted, A) at C with the culture medium changed e ery days. Cells of passage at 80 0% con luence were used for further studies.
Cytotoxicity assay
Osteoblasts were cultured incontaining 10% FB and 1% ( / ) antibiotics and seeded into a -well plates at a density of 1 10 cells/well for 24h. The medium was replaced with a medium containing AP prepared with different concentrations (0-100 ) in triplicate for days. After exposure period, 10ul of 5 mg/ml -(4,5)-dimethylthiahiazo(-z-y1)-,5-diphenytetrazoliumromide ( TT, ibco, A) solution was added to each wells and further incubated at C. After 4 hours, culture medium was remo ed and dimethyl sulfoxide (D O, ibco, A) was added with 100 l per well for crystal solubilization. The plates were placed in the dar at C, with continuous gentle sha ing for 10 min to thoroughly dissol e the crystal. The spectrometric absorbance at 5 0 nm was read using a microplate reader (Thermo Fisher cienti ic, ). As determined by TT analysis, Results of showed that AP of 8. 2 could best promote cell growth. Therefore, concentrations of 4.4 , 8. 2 and 1 .84
were chosen for further in estigations.
Cell proliferation analysis
Cells were treated with AP at four concentrations (0 as control, 4.4 , 8. 2 , and 1 .84 ) for , 5 and days. Proliferation of osteoblasts cultured with arious concentrations of AP was detected by the TT assay. Brei ly, 100
TT was added in each well at C for 4 h, and then the supernatant was discarded and dissol ed in 1m D O. Before test, all samples were transferred to -well plates, with a concentration of 200 /well. The absor bance was measured at 5 0 and recorded under a microplate reader (Bio-Rad 550, A).
Alkaline phosphatase (ALP) activity
Al aline phosphatase (A P) acti ity assay was carried out by using A P detection reagent it (Nan ing iancheng Bioengineering Research nstitute, China) following the manufacturer s instructions. After centrifuged at 2500 rpm for 10min, the supernatant of the medium was har ested for subse uent assay. After adding buffer solution, matrix solution, water bathing and de eloping, the optical density (OD) alue was detected at 520 with a microplate reader (Thermo Fisher cienti ic, ). ubse uently, the acti ity alue was calculated with computational formula. ach sample was analyzed in triplicate to reduce randomization error.
Cell viability assay
ital staining was performed with 5 phosphate buffered luorescein diacetate (FDA) ( ife Technologies (AB n itrogen) A)/ and 20 propidium iodide (P , ife Technologies (AB n itrogen), A)) in phosphate buffered saline (PB ) incubated in the dar for 5 min at °C. Analysis was performed with a laser scanning confocal microscope (Ni on A1, apan).
Cell morphology
After cultured for , 5 and days respecti ely, cells were ixed with 4% paraformaldehyde for 0 min and successi ely stained by hematoxylin-eosin ( ) using it ( iancheng Biotech, China). Finally, cells were obser ed and photographed utilizing an pright microscope ( eica D 1000, ermany).
Immunohistochemical staining
For immunohistochemical staining, cells were subse uently ixed with 4% paraformaldehyde and endogenous peroxidase was uenched with % 2O2 in methanol. Prior to staining, non-speci ic binding was bloc ed by goat serum for 10 min at room temperature. They were then incubated with primary antibody (osteocalcin, OCN, Bioss, China) at °C for h. The horseradish peroxidase-con ugated goatantirabbit g Ab ( igma) was applied at °C for 1 h. The chromogenic reaction of OCN was isualized by , -diaminobenzidine tetrahydrochloride (DAB) it (Boster, China) and counterstained with haematoxylin. The cells were obser ed and photographed utilizing an pright microscope ( eica D 1000, ermany). 
Western blot analysis
Cells were washed with cold phosphate-buffered saline ( ehicle), and whole-cell lysates were prepared by the addition of lysis buffer igma-Aldrich containing a protease inhibitor mixture igma-Aldrich. Cytoplasmic and nuclear fractions were prepared using the nuclear and cytoplasmic extraction it( ey N BioT C , China) according to the manufacturer s protocol. 0 50 ug of protein was loaded per lane and separated on a 10% polyacrylamide gel, followed by transfer to a P DF membrane ( illipore, Billerica, A, A) by electroblotting. embrane was bloc ed for nonspeci ic binding in 5% nonfat dry mil and followed by incubation with a primary antibody (Abcam) at 4°C o ernight. The membranes were washed and probed with an Alexainfrared dye-con ugated secondary antibodies ( n itrogen) and isualized by the Odyssey nfrared maging ystem ( -COR) according to the manufacturer s instructions.
Gene expression analysis
RNA was extracted from cell layers at days , 5 and using an RNeasy RNA extraction it (Tiangen Biotechnology Bei ing, China) according to the manufacturer s instructions, and uanti ied spectrometrically.
tarting from 1 ug RNA, 20 u of cDNA were synthesised using re erse transcription it (Fermentas company, A)and and then cDNAs were ampli ied using BR-reen mix it (Roche company, ermany). uantitati e RT-PCR reactions were performed and monitored using the astercycler eprealplex Detection ystem ( ppendorf, amburg, ermany) and Real aster ixCyber reen ( ppendorf). enes of interest were analysed in cDNA samples (5 u , 50 u /reaction) using the 2-CT method relati e to APD . ach sample was repeated three times for each gene. The primers used for PCR were designed as follows Table 1 .
Statistical analysis
The data were analyzed using the P 1 .0 statistical pac age(Chicago, A). The data are presented as the mean . One-way ANO A and tudent sunpaired t-test were used for statistical analysis. For all tests, P<0.05 was considered to be statistically signi icant.
Results

Cytotoxicity assay
As shown in Fig. 1 AP signi icantly accelerated cell growth with the more ob ious effect at the dose of 8. 2 (P<0.05). n contrast, the concentration ranging from 1 .84 to 0 of AP showed inhibition of proliferation of rat osteoblasts in itro, compared Fig. 1 (B) shows that the proliferation of osteoblasts is both time-and dose-dependent. Osteoblasts cultured with 4.4 and 8. 2 of AP grew faster than both control and 1 .84 group (P<0.05) in the same culture period. Among the three AP groups, 8. 2 of AP was the optimal concentration which stimulated the proliferation of cells the most prominently.
Cell proliferation
Alkaline phosphatase (ALP) activity
As shown in Fig. 1 (C) , osteoblasts treated with both 4.4 and 8. 2
of AP exhibited higher A P acti ity than those in the control at day , 5 and . By contrast, the dose of 1 .84 showed lower A P than the control group. On the whole, the trend of A P acti ity increased from day to . The results of A P acti ity demonstrated that AP was bene icial to osteogenic differentiation, especially at the concentration of 4.4 (P<0.01). 
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Cell viability assay Cell iability was determined by FDA/P staining (Fig. ) , in which iable cells were stained green and dead cells were stained red. The results re ealed that 4.4 and 8. 2 of AP exert positi e effect on osteoblast sur i al, which was in accordance with the result of cell proliferation by TT analysis. 1 .84 of AP presents an inferior position in osteoblast sur i al .Among the experimental groups, concentration of 8. 2 was superior to others.
Cell morphology aluation of osteoblasts morphology by staining showed that osteoblasts treated by 4.4 and 8. 2 of AP grew better than control and 1 .84 of AP at the same time point of treatment (Fig. 4) . n the AP groups, the most cells were present after treated with 8. 2 of AP. Fig. 2 . uantitati e real-time PCR was used to analyze the progression of the expression of osteogenic genes OCN , B P-2, A P, B P, R N 2 in osteoblasts cultured in arious concentrations of AP for , 5, days. The control group alue was set to 1 and alues are expressed as means . *,# indicate P < 0.05, **,## indicate P < 0.01 and ***, ### indicate P < 0.001) (B P-2 bone morphogenetic protein-2, Runx2 runt-related transcription factor 2, A P al aline phosphatase, B P bone sialoprotein, OCN osteocalcin).
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Immunohistochemical staining
We e aluated the deposition of matrix in rat osteoblasts in itro with immunohistochemical staining of OCN (Fig. 5 (A-P) ).The negati e control staining was presented in Fig. 5 ( ). There were more OCN positi e staining (as shown in dar -brown) in 4.4 , 8. 2 AP groups than the control group, and the positi e rate was showed in Fig. 5 (R) . n addition, AP at dose of 1 .84 was inferior to others in terms of OCN staing. t is suggested that AP at dose of 4.4 and 8. 2 exerted pro-osteogenic effect on mature osteoblasts.
Gene expression analysis
The expression of A P, OCN, B P, B P2, Runx2, -catenin, Wnt4, b, WNT5a and Fzd2 was detected at day ,5, , (Fig. 2, Fig. (A) ).When compared to APD mRNA le el, the relati e le els of the A P, OCN, B P, B P2, Runx2, -catenin, Wnt4 mRNA were all signi icantly up-regulated by 4.4 , 8. 2 AP than the control group.On the contrary, gene expression was cutting down by 1 .84 AP. Among all the groups, AP at the concentration of 8. 2 exhibited the best performance with regard to the up-regulation of expression of OCN, B P, B P2, Runx2, -catenin, Wnt4 genes. n line with the A P acti ity assay, AP at dose of 4.4 indicated the best effect on A P gene expression. Wnt5a, Fzd2 and s -b were all signi icantly down regulated by AP treatment at a dose of 8. 2 (P<0.05). t is indicated that the down regulated Wnt5a, Fzd2 and s -b was associated with the up-regulated Wnt4, -catenin and osteo-genes. 
Discussion
Andrographispaniculata (A. paniculata) has a long history of therapy in arious diseases without ob ious ad erse side effects since ancient China. As the main acti e constituent of A. paniculata, AP was reported to pre ent osteoclast-related bone resorption [14] . Besides, AP has the ability to acti ate the canonical Wnt signalling pathway which is crucial for bone formation and inhibition of osteoporosis. All the indings suggested that AP may be potential agent to treat osteoporosis, which may exert an effect on osteoblastic bone formation.
During the bone formation, the osteoblasts will express numerous mar ers such as A P, B P, OCN and arious cyto ines. A P, which is one of the well de ined mar ers of pre-osteoblast differentiation, plays an important role in osteoid formation and bone mineralization, ust as a catalyst in the process of bone formation [2 ] . Our results showed that AP could signi icantly increase the le el of A P, indicating that AP can promote the preosteoblast maturation which is essential for mineralization. As a conse uence of continuously increased A P heralding the differentiation stage, B P and OCN which were speci ic mar ers in mineralized tissues [2 -2 ] were also up-regulated by AP. The results indicated that AP has potent regulati e effects on osteoblasts maturation.
Runx2 is a noncollagenous, highly conser ed transcription factor in ol ed in the regulation of mineralized matrix of bone. utations in the Runx2 gene in mouse and human lead to cleidocranial dysplasia and critical defects in bone formation [ 0, 1] n our study, upregulated expression of Runx2 was obser ed by rt-PCR in osteoblasts treated with AP at dose of 4.4 and 8. 2 as compared to control (Fig. 2) . t has been reported that Runx2 binds to the osteoblast speci ic cis acting element which is found in the promoter region of all ma or osteoblast speci ic genes li e OCN, B P, A P and control their expression [ 2] . ence, it is reasonable to deduce that AP may regulate the osteogenic related gene expression through the modulation of Runx2 in osteoblastic cells.
To speci ically now the molecular target of AP, we next characterized the cellular signaling e ents that may be acti ated by AP. i en the importance of the canonical Wnt signalling pathway which can be acti ated by AP [24], Wnt/ -catenin signaling related genes were identi ied. Our study showed that the expression of -catenin, Wnt4 mRNA was signi icantly up-regulated, and b, WNT5a, Fzd2 downregulated by AP, suggesting that AP could affect the osteoblasts metabolism by acti ating the Wnt/ -catenin signaling pathway. Wnt 4 and -catenin plays important role in osteogenesis and bone formation, which pre ents s eletal aging and bone loss in vivo [22] . ncreased expression of Wnt 4 and -catenin after treatment of AP re eals the proosteogenic effect of AP. On the other hand, inhibition of other wnt-related genes li e b, Wnt5a, Fzd2 by AP indicates the potential of AP on pre ention of bone loss. n the process of osteogensis, Wnt5a antagonizes Wnt/ -catenin signaling through the Wnt/Calcium pathway [ ] and -catenin degradation by promoting b [ 4] . tudies ha e shown that haploinsuf iciency of -b can partially rescue dwar ism caused by c P-dependent protein inase de iciency [ 5] . n the -catenin -independent pathway, Wnt5a acti ated Rac by the ac uirement of Frizzled2 (Fzd2) through a clathrinmediated route in response [ ]. Thus, suppression of b, Wnt5a, Fzd2 to some extent may contribute to osteogenesis.
At the molecular le el shown in Fig. , the AP-acti ated Wnt signalling pathway may be partially associated with increased abundance of the transcription factors -catenin and B P2, all crucial for s eletal growth and de elopment. Runx2 is also a direct target of the canonical WNT signaling pathway [ ], which is upregulated by -catenin that accumulates in the nucleus and binds F-1/TCF to promote differentiation and proliferation of osteoblasts [ 8] . B P2, signaling component distincted from the nown Wnt/ -catenin signal, may stimulate processes that cooperate with acti ated -catenin to promote osteoblast differentiation [ , 40 ]. ascular calci ication in chronic idney disease is induced by B P2
ia Wnt/ -catenin pathway [41] . Osteoblasts cultured in itro, which ha e similar biological characteristics of osteoblasts in vivo, is the primary means to study the metabolic diseases of s eleton [42] . n the present Cellular Physiology and Biochemistry study, AP has an effect on the proliferation of osteoblasts in itro in a dose-dependent manner, as e idenced by TT analysis, cell iability assay and histological e aluation. specially at the concentration of 8. 2 , AP could best support cell growth in all the groups. The results suggested the potency of AP as an osteogenic enhancer in itro may broaden its utility in therapy of osteoporosis in clinic.
n conclusion, our results demonstrate for the irst time that AP exerts an effect on osteoblastogenesis by acti ating wnt/ -catenin signaling pathway. These acti ities may be partially controlled by transcription factors -catenin and Runx2, which were upregulated after treatment with AP. The study indicates AP can be used as a pro-osteogenic agent for the therapy of osteoporosis. Ne ertheless, we should stay aware that this study presents some limitations, and further studies are re uired to fully determine the contribution of AP properties in vivo.
